Phenylephrine/tropicamide - Eyenovia

Drug Profile

Phenylephrine/tropicamide - Eyenovia

Alternative Names: Dx 102; Tropicamide/phenylephrine - Eyenovia

Latest Information Update: 12 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Eyenovia
  • Class Antihyperglycaemics
  • Mechanism of Action Alpha 1 adrenergic receptor agonists; Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Mydriasis

Most Recent Events

  • 12 Jul 2018 Chemical structure information added
  • 05 Jun 2018 Eyenovia receives patent allowances for micro-therapeutic ophthalmic delivery system in USA
  • 30 Oct 2017 Adverse events, pharmacokinetics and pharmacodynamics data from a phase II EYE 102 trial in Mydriasis released by Eyenovia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top